nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.05.2004 | Concise Article

Blastocystis hominis as a cause of hypoalbuminemia and anasarca

verfasst von: E. Nassir, J. Awad, A. B. Abel, J. Khoury, M. Shay, F. Lejbkowicz

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

The protozoan Blastocystis hominis has been considered nonpathogenic, but this classification has come under scrutiny in light of reports in the medical literature indicating it could be the cause of intestinal disorders and, in one case, hypoalbuminemia. Reported here is a severe case of infection with B. hominis that caused acute gastroenteritis with prolonged diarrhea, hypoalbuminemia and anasarca. The diagnosis was based on the parasitological finding, since no other pathological evidence was found. The patient responded favorably to treatment with metronidazole for 10 days. This case supports the idea that B. hominis should be considered as a cause of opportunistic infection in debilitated patients despite the controversy surrounding its pathogenicity.

Zierdt CH (1988) Blastocystis hominis, a long-misunderstood intestinal parasite. Parasitol Today 4:15–17CrossRef

Windsor JJ, Macfarlane L, Whiteside TM, Chalmers RM, Thomas AL, Joynson DH (2001) Blastocystis hominis: a common yet neglected human parasite. Br J Biomed Sci 58:129–130CrossRefPubMed

Waring L, Reed C (2001) Blastocystis hominis. Causative organism or harmless commensal? Aust Fam Physician 30:374PubMed

Qadri HS (1989) Clinical significance of Blastocystis hominis. J Clin Microbiol 27:2407–2409PubMed

Nimri LF, Batchoun R (1994) Intestinal colonization of symptomatic and asymptomatic school children with Blastocystis hominis. J Clin Microbiol 32:2865–2866PubMed

Lee MG, Rawlins SC, Didier M, DeCeulaer K (1990) Infective arthritis due to Blastocystis hominis. Ann Rheum Dis 49:192–193PubMed

Urbina D, Arzuza O, Young G, Parra E, Castro R, Puello M (2003) Rotavirus type A and other enteric pathogens in stool sample from children with acute diarrhea on the Colombian northern coast. Int Microbiol 6:27–32PubMed

Svenungsson B, Lagergren A, Ekwall E, Evengard B, Hedlund KO, Karnell A, Lofdahl S, Svensson L, Weintraub A (2000) Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 30:770–778CrossRefPubMed

Garavelli PL (1991) The therapy of blastocystosis. J Chemother 3(Suppl 1):245–246

10.

Nimri LF (1993) Evidence of an epidemic of Blastocystis hominis infections in preschool children in northern Jordan. J Clin Microbiol 31:2706–2708PubMed

11.

Khalifa AM (1999) Diagnosis of Blastocystis hominis by different staining techniques. J Egypt Soc Parasitol 29:157–165PubMed

12.

Windsor JJ, Macfarlane L, Hughes-Thapa G, Jones SK, Whiteside TM (2002) Incidence of Blastocystis hominis in faecal samples submitted for routine microbiological analysis. Br J Biomed Sci 59:154–157PubMed

13.

Suresh K, Smith H, Kumar S (2004) Comparison of methods for detecting Blastocystis hominis. Eur J Clin Microbiol Infect Dis 23. DOI 10.1007/s10096-004-1123-7

14.

Vdovenko AA (2000) Blastocystis hominis: origin and significance of vacuolar and granular forms. Parasitol Res 86:8–10PubMed

15.

Moe KT, Singh M, Howe J, Ho LC, Tan SW, Chen XQ, Yap EH (1999) Development of Blastocystis hominis cysts into vacuolar forms in vitro. Parasitol Res 85:103–108CrossRefPubMed

16.

Wang KX, Li CP, Wang J, Cui YB (2002) Epidemiological survey of Blastocystis hominis in Huainan City, Anhui Province, China. World J Gastroenterol 8:928–932PubMed

17.

Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, Cacopardo B (2003) A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 10:128–130PubMed

18.

Ok UZ, Girginkardesler N, Balcioglu C, Ertan P, Pirildar T, Kilimcioglu AA (1999) Effect of trimethoprim–sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 94:3245–3247CrossRefPubMed

19.

Wolfe MS (1982) The treatment of intestinal protozoan infections. Med Clin N Am 66:707–720PubMed

20.

Albrecht H, Stellbrink HJ, Koperski K, Greten H (1995) Blastocystis hominis in human immunodeficiency virus-related diarrhea. Scand J Gastroenterol 30:909–914PubMed

21.

Cegielski JP, Msengi AE, Dukes CS, Mbise R, Redding-Lallinger R, Minjas JN, Wilson ML, Shao J, Durack DT (1993) Intestinal parasites and HIV infection in Tanzanian children with chronic diarrhea. AIDS 7:213–221PubMed

22.

Levy Y, George J, Shoenfeld Y (1996) Severe Blastocystis hominis in an elderly man. J Infect 33:57–59PubMed

23.

Cheng HS, Guo YL, Shin JW (2003) Hematological effects of Blastocystis hominis infection in male foreign workers in Taiwan. Parasitol Res 90:48–51PubMed

24.

Sheehan DJ, Raucher BG, McKitrick JC (1986) Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol 24:548–550PubMed

25.

Arribas JM, Fernandez GH, Escalera GI, Pardilla AI, Martin TA, Gonzalez De La Rosa JB (2001) Acute infectious lymphocytosis associated to Giardia lamblia and Blastocystis hominis coinfection [Article in Spanish]. An Esp Pediatr 54:518–520

26.

Kaneda Y, Horiki N, Cheng XJ, Fujita Y, Maruyama M, Tachibana H (2001) Ribodemes of Blastocystis hominis isolated in Japan. Am J Trop Med Hyg 65:393–396PubMed

27.

Yoshikawa H, Abe N, Iwasawa M, Kitano S, Nagano I, Wu Z, Takahashi Y (2000) Genomic analysis of Blastocystis hominis strains isolated from two long-term health care facilities. J Clin Microbiol 38:1324–1330PubMed

28.

Tasova Y, Sahin B, Koltas S, Paydas S (2000) Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama 54:133–136PubMed

29.

Menon BS, Abdullah MS, Mahamud F, Singh B (1999) Intestinal parasites in Malaysian children with cancer. J Trop Pediatr 45:241–242PubMed

30.

Horiki N, Kaneda Y, Maruyama M, Fujita Y, Tachibana H (1999) Intestinal blockage by carcinoma and Blastocystis hominis infection. Am J Trop Med Hyg 60:400–402PubMed

31.

Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G (1999) Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 18:436–439CrossRefPubMed

32.

Cirioni O, Giacometti A, Drenaggi D, Ancarani F, Scalise G (1999) Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur J Epidemiol 15:389–393PubMed

33.

Taamasri P, Leelayoova S, Rangsin R, Naaglor T, Ketupanya A, Mungthin M (2002) Prevalence of Blastocystis hominis carriage in Thai army personnel based in Chonburi, Thailand. Mil Med 167:643–646PubMed

Titel: Blastocystis hominis as a cause of hypoalbuminemia and anasarca
verfasst von: E. Nassir
J. Awad
A. B. Abel
J. Khoury
M. Shay
F. Lejbkowicz
Publikationsdatum: 01.05.2004
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2004
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-004-1122-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2004

Plasma interleukin-6 levels in Mediterranean spotted fever

Severe peritonitis due to Balantidium coli acquired in France

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

May 2004

Metabolically deficient methicillin-resistant Staphylococcus aureus as cause of chronic post-thoracotomy sternal wound infection